Search

everythinglearnresearchcommunity

for

Search:↓

A patient with PPP had rare skin reactions to adalimumab, which improved after stopping smoking and continuing acitretin.

UTMD with diclofenac and Doxil® improves cancer treatment by boosting immune response and reducing tumor-supporting cells.

A woman's hair grew back while she was taking sulphasalazine for arthritis.

Baricitinib is a safe and effective alternative for alopecia areata patients who do not respond to tofacitinib.

Immunological treatment improved both neuropathy and alopecia.

Tofacitinib helps improve skin conditions in people with Down syndrome, especially alopecia areata.

Tofacitinib treatment is used for teenagers with alopecia areata.

Microneedle arrays deliver botulinum toxin effectively for sweat suppression, similar to injections.

Baricitinib quickly improved severe alopecia areata, with almost total hair regrowth in three months.

Tofacitinib is more effective than methotrexate for treating moderate-to-severe alopecia areata.

Azathioprine can cause severe hair loss and low white blood cell count in lupus patients.

Oral tofacitinib shows promise in treating atopic dermatitis and alopecia areata, but only slight improvement in vitiligo.

The treatment was effective for lupus nephritis with manageable side effects.

Weekly bicalutamide is safe and effective, with 50 mg/week recommended.

Baricitinib may not always prevent relapse in alopecia areata.

Olumiant® (Baricitinib) is effective for treating hair loss from Alopecia Areata.

JAK inhibitors may help treat alopecia areata by reversing hair loss.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Baricitinib helped a woman with severe hair loss regrow almost all her hair without side effects.

A woman developed hair loss after starting a treatment with adalimumab, suggesting this medication might cause hair loss.

Tofacitinib taken by mouth helps treat hair loss in children.

Using both bone marrow concentrate and platelet-rich plasma together improves skin wound healing in mice.

JAK inhibitors can effectively regrow hair in alopecia areata patients, but ongoing treatment is needed to maintain results.

Careful management of blood thinners is crucial for lupus patients with APS.

Ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata.

JAK inhibitors show promise in treating skin conditions like eczema, hair loss, and vitiligo but need more safety research.

Etanercept, a psoriasis treatment, caused hair loss in a patient.

Irish dermatologists urgently need guidelines for using JAK inhibitors in treating alopecia areata.

SIG-1451 could be a promising new treatment for atopic dermatitis.